Neurology Central

Cerebral microbleeds as a biomarker in Alzheimer’s disease? A review in the field


Cerebral microbleeds (CMBs) are a marker of small vessel disease, increasingly recognized as being of importance in the Alzheimer’s disease (AD) process. CMBs influence in AD, and its longitudinal impact on disease progression is however still unknown. CMBs show several associations with AD across studies, are associated with decreased cerebrospinal fluid amyloid levels and are related with the ApoE ϵ4 allele, as well as other imaging manifestations typical for small vessel disease.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.